• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by American Well Corporation (Amendment)

    2/9/24 4:19:51 PM ET
    $AMWL
    Business Services
    Consumer Discretionary
    Get the next $AMWL alert in real time by email
    SC 13G/A 1 p24-0217sc13ga.htm AMERICAN WELL CORPORATION

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    SCHEDULE 13G/A
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 2)*
     

    American Well Corporation

    (Name of Issuer)
     

    Class A Common Stock, par value $0.01 per share

    (Title of Class of Securities)
     

    03044L105

    (CUSIP Number)
     

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    ¨ Rule 13d-1(b)
    ý Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 7 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 03044L105

    13G/APage 2 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

     

    Senvest Management, LLC

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    23,529,964

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    23,529,964

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    23,529,964

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    9.2%

    12

    TYPE OF REPORTING PERSON

    OO, IA

             

     

     

     

    CUSIP No. 03044L105

    13G/APage 3 of 7 Pages

     

    1

    NAME OF REPORTING PERSON

     

    Richard Mashaal

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Canada

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    23,529,964

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    23,529,964

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    23,529,964

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    9.2%

    12

    TYPE OF REPORTING PERSON

    IN, HC

             

     

     

    CUSIP No. 03044L105

    13G/APage 4 of 7 Pages

     

    Item 1(a). Name of Issuer.
      American Well Corporation (the "Issuer")

     

    Item 1(b). Address of Issuer's Principal Executive Offices.
      75 State Street, 26th Floor, Boston, Massachusetts 02109

     

    Item 2(a). Name of Person Filing.
      This statement is filed by Senvest Management, LLC and Richard Mashaal.
       
      The reported securities are held in the account of Senvest Master Fund, LP and Senvest Technology Partners Master Fund, LP (collectively, the "Investment Vehicles").
       
      Senvest Management, LLC may be deemed to beneficially own the securities held by the Investment Vehicles by virtue of Senvest Management, LLC's position as investment manager of the Investment Vehicles. Mr. Mashaal may be deemed to beneficially own the securities held by the Investment Vehicles by virtue of Mr. Mashaal's status as the managing member of Senvest Management, LLC. None of the foregoing should be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the securities reported herein.

     

    Item 2(b). Address of Principal Business Office.
     

    Senvest Management, LLC

    540 Madison Avenue, 32nd Floor

    New York, New York 10022

       
     

    Richard Mashaal

    c/o Senvest Management, LLC

    540 Madison Avenue, 32nd Floor

    New York, New York 10022

     

    Item 2(c). Place of Organization.
      Senvest Management, LLC – Delaware
       
      Richard Mashaal – Canada

     

    Item 2(d). Title of Class of Securities.
      Class A Common Stock, par value $0.01 per share

     

    Item 2(e). CUSIP Number.
      03044L105

     

     

    CUSIP No. 03044L105

    13G/APage 5 of 7 Pages

     

    Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a:
      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
      (f) ¨

    An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

      (g) ¨

    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

     

      (h) ¨

    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);

     

      (i) ¨

    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     

      (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

     

    If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please

    specify the type of institution:                                                                                       

     

    Item 4. Ownership.
      The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentages set forth in this Schedule 13G/A are calculated based upon an aggregate of 254,623,284 shares of Class A Common Stock outstanding as of October 27, 2023, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the Securities and Exchange Commission on November 1, 2023.

     

    Item 5. Ownership of Five Percent or Less of a Class.
      Not applicable.

     

     

    CUSIP No. 03044L105

    13G/APage 6 of 7 Pages

     

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
      The Investment Vehicles have the right to receive and the power to direct the receipt of dividends from, and the proceeds from the sale of the Class A Common Stock. Senvest Master Fund, LP has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5% of the Class A Common Stock.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
      Not applicable.

     

    Item 8. Identification and Classification of Members of the Group.
      Not applicable.

     

    Item 9. Notice of Dissolution of Group.
      Not applicable.

     

    Item 10. Certification.
      By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

    CUSIP No. 03044L105

    13G/APage 7 of 7 Pages

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Date:  February 9, 2024  
      SENVEST MANAGEMENT, LLC
       
         
      By: /s/ Bobby Trahanas
      Name:  Bobby Trahanas
      Title:    Chief Compliance Officer
       
       
       
       
      /s/ Richard Mashaal
      RICHARD MASHAAL

     

     

    Get the next $AMWL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMWL

    DatePrice TargetRatingAnalyst
    1/13/2025$15.00Equal Weight → Overweight
    Wells Fargo
    8/3/2023$5.00 → $2.50Overweight → Equal-Weight
    Morgan Stanley
    3/23/2023$5.00 → $2.50Outperform → Market Perform
    TD Cowen
    2/27/2023$5.00 → $3.50Overweight → Neutral
    Piper Sandler
    1/4/2023$4.20Neutral → Buy
    BofA Securities
    9/7/2022$5.00Hold
    Truist
    4/14/2022$6.00Buy
    Guggenheim
    4/1/2022$5.00Neutral
    Credit Suisse
    More analyst ratings

    $AMWL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Amwell makes grant to new employee under inducement plan

      BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class A common stock to one new employee. The grant was offered as material inducement to the employee's employment with Amwell. The RSUs will vest as follows, subject to the employee's continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date ("Initial Vesting Date"), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first calendar day of the month following the

      5/6/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® Announces Results for First Quarter 2025

      BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. About Amwell Amwell offers payers and

      5/1/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® to participate in upcoming investor conferences

      BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the following upcoming investor conferences:   On May 8, Mark Hirschhorn, chief financial officer and chief operating officer, will participate in one-on-one meetings at the Needham & Co. Virtual Technology and Services Conference held virtually. On June 24, Hirschhorn will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference in New York City.    About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technolo

      4/24/25 7:30:00 AM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Accounting Officer Mcneice Paul Francis sold $747 worth of shares (113 units at $6.61), decreasing direct ownership by 0.78% to 14,366 units (SEC Form 4)

      4 - American Well Corp (0001393584) (Issuer)

      6/4/25 5:01:52 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • President, International Gotlib Phyllis sold $31,628 worth of shares (4,782 units at $6.61), decreasing direct ownership by 3% to 141,849 units (SEC Form 4)

      4 - American Well Corp (0001393584) (Issuer)

      6/4/25 5:01:14 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • President, International Gotlib Phyllis sold $2,155 worth of shares (299 units at $7.21), decreasing direct ownership by 0.20% to 146,631 units (SEC Form 4)

      4 - American Well Corp (0001393584) (Issuer)

      5/5/25 4:31:36 PM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Leadership Updates

    Live Leadership Updates

    See more
    • Amwell announces new chief financial officer

      BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeeding Robert "Bob" Shepardson, who has been in the role since 2021. Hirschhorn will oversee Amwell's financial operations, enterprisewide optimization and capital allocation activities, and will play a meaningful leadership role in guiding the company's strategy to support its long-term growth objectives and enhance shareholder value.   Hirschhorn is a healthcare technology industry leader, with over three decades of experience in financial and strategic operations, having served in senior executiv

      10/15/24 4:30:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors

      Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13. "Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell's path to profitability. Ricky's strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growth, while remaining committed to enabling our clients to achieve their goals. We are pleased to welcome Ricky to the team," said Ido Schoenberg, M.D., CEO and chairman, Amwell. Ms. Gol

      6/17/24 8:05:00 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

      ALACHUA, Fla. and TAMPA, Fla., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce today the appointment of Mrs. Kathy Weiler to its Board of Directors, effective December 20, 2023. Weiler, a senior executive with 20+ years of experience and proven track record in driving strategic commercial initiatives, will serve on the Board's Governance, Nominating and Sustainability Committee, and the Quality, Compliance, and Portfolio Management Committee. "I am happy to welcome Kathy to the Board as Axogen is approaching an exciting inflection point in its journ

      12/26/23 4:15:00 PM ET
      $AMWL
      $AXGN
      Business Services
      Consumer Discretionary
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $AMWL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Amwell upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Amwell from Equal Weight to Overweight and set a new price target of $15.00

      1/13/25 7:29:38 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Amwell from Overweight to Equal-Weight and set a new price target of $2.50 from $5.00 previously

      8/3/23 6:19:10 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell downgraded by TD Cowen with a new price target

      TD Cowen downgraded Amwell from Outperform to Market Perform and set a new price target of $2.50 from $5.00 previously

      3/23/23 7:15:52 AM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Financials

    Live finance-specific insights

    See more
    • Amwell® Announces Results for First Quarter 2025

      BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. About Amwell Amwell offers payers and

      5/1/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® to report first quarter 2025 operating results

      BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days. About Amwell  Amwell offers payers and

      4/17/25 7:05:00 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® Announces Results for Fourth Quarter and Full Year 2024

      BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Feb. 12. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/zsp4abpw. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. Abo

      2/12/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by American Well Corporation

      SCHEDULE 13G/A - American Well Corp (0001393584) (Subject)

      5/15/25 4:21:34 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • SEC Form 10-Q filed by American Well Corporation

      10-Q - American Well Corp (0001393584) (Filer)

      5/1/25 4:13:22 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • American Well Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - American Well Corp (0001393584) (Filer)

      5/1/25 4:10:12 PM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by American Well Corporation

      SC 13G/A - American Well Corp (0001393584) (Subject)

      11/12/24 4:43:25 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G filed by American Well Corporation

      SC 13G - American Well Corp (0001393584) (Subject)

      11/6/24 4:14:27 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G filed by American Well Corporation

      SC 13G - American Well Corp (0001393584) (Subject)

      11/4/24 11:53:44 AM ET
      $AMWL
      Business Services
      Consumer Discretionary